ABOUT THE AUTHORS

Dinesh Singh Thakur is a trained chemical engineer. He turned whistleblower against Ranbaxy after witnessing large scale data fraud at the company. His efforts led to Ranbaxy pleading guilty to violating American law before an American court in 2013. The company agreed to pay a penalty of $500 million dollars as a part of its guilty plea. For his actions, he received the Joe A. Callaway Award for Civic Courage and the ACFE Cliff Robertson Sentinel Award. Since 2014, he has advocated for reform of India’s colonial era Drugs & Cosmetics Act, 1940 and has founded an advocacy group called the Citizens for Affordable, Safe & Effective Medicine (CASEM). He is also the founder and President of the Thakur Family Foundation, a philanthropic organisation that provides grants for research on public health and health journalism in India.

Prashant Reddy Thikkavarapu studied law at the National Law School of India University, Bangalore and Stanford Law School, California, as a J.N. Tata Scholar. After a stint in the litigation teams at two Delhi-based law firms specialising in intellectual property law, he worked in academia and thinktanks in New Delhi, Hyderabad and Singapore. Over the last few years, he has been advising Dinesh Thakur in his advocacy campaign for the reform of drug regulatory law in India. Prashant is also the co-author of Create, Copy, Disrupt: India’s Intellectual Property Dilemmas (OUP 2017).

Format
Royal Hardback
Page Extent
512
Publication Date
10 Oct 2022
Category
General medicine / Medicine and law / Pharma and law / Society & culture